Terms: = Leukemia AND IRF4, LSIRF, 3662, ENSG00000137265, Q15306
149 results:
1. Vulnerability to APOBEC3G linked to the pathogenicity of deltaretroviruses.
Shichijo T; Yasunaga JI; Sato K; Nosaka K; Toyoda K; Watanabe M; Zhang W; Koyanagi Y; Murphy EL; Bruhn RL; Koh KR; Akari H; Ikeda T; Harris RS; Green PL; Matsuoka M
Proc Natl Acad Sci U S A; 2024 Mar; 121(13):e2309925121. PubMed ID: 38502701
[TBL] [Abstract] [Full Text] [Related]
2. Evidence of the Role of Inflammation and the Hormonal Environment in the Pathogenesis of Adrenal Myelolipomas in Congenital Adrenal Hyperplasia.
Kolli V; Frucci E; da Cunha IW; Iben JR; Kim SA; Mallappa A; Li T; Faucz FR; Kebebew E; Nilubol N; Quezado MM; Merke DP
Int J Mol Sci; 2024 Feb; 25(5):. PubMed ID: 38473790
[TBL] [Abstract] [Full Text] [Related]
3. Assessing Interferon Regulatory Factor 4 Complex Formation: Differential Behavior of Homocomplexes Versus Heterocomplexes Induced by Mutations.
Li Y; Hirano S; Sato K; Osawa M; Nagaoka H
Biochemistry; 2024 Mar; 63(6):767-776. PubMed ID: 38439718
[TBL] [Abstract] [Full Text] [Related]
4. [Expression and Clinical Significance of Helper T Cells 9 and Its Sytokines Interleukin 9 in Chronic Lymphocytic leukemia].
Shabaaiti T; Pang NN; Xierenguli A; Nazhakaiti Y; Guo S; Zhang RR; Gong S; Qu JH
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1663-1669. PubMed ID: 38071043
[TBL] [Abstract] [Full Text] [Related]
5. Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies.
Nicosia L; Spencer GJ; Brooks N; Amaral FMR; Basma NJ; Chadwick JA; Revell B; Wingelhofer B; Maiques-Diaz A; Sinclair O; Camera F; Ciceri F; Wiseman DH; Pegg N; West W; Knurowski T; Frese K; Clegg K; Campbell VL; Cavet J; Copland M; Searle E; Somervaille TCP
Cancer Cell; 2023 Dec; 41(12):2136-2153.e13. PubMed ID: 37995682
[TBL] [Abstract] [Full Text] [Related]
6. T helper type 9 cell response and its role in the neurological clinic of patients with Human T-lymphotropic virus 1.
de Sena Rodrigues Júnior R; Antonia Nunes Gomes J; Alberto da Silva Dias G; Fujihara S; Toshimitsu Yoshikawa G; Vilela Lopes Koyama R; Catarina Medeiros Sousa R; Antonio Simões Quaresma J; Thais Fuzii H
Immunobiology; 2023 Nov; 228(6):152740. PubMed ID: 37657359
[TBL] [Abstract] [Full Text] [Related]
7. The clinical and molecular taxonomy of t(14;18)-negative follicular lymphomas.
Salaverria I; Weigert O; Quintanilla-Martinez L
Blood Adv; 2023 Sep; 7(18):5258-5271. PubMed ID: 37561599
[TBL] [Abstract] [Full Text] [Related]
8. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with irf4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
9. Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.
Kameda T; Kataoka K; Kamiunten A; Hidaka M; Miyoshi H; Nakano N; Nosaka K; Yoshimitsu M; Yasunaga JI; Kogure Y; Shide K; Miyahara M; Sakamoto T; Akizuki K; Hidaka T; Kubuki Y; Koya J; Kawano N; Yamashita K; Kawano H; Toyama T; Maeda K; Marutsuka K; Imaizumi Y; Kato K; Sugio T; Tokunaga M; Tashiro Y; Takaori-Kondo A; Miyazaki Y; Akashi K; Ishitsuka K; Matsuoka M; Ohshima K; Watanabe T; Kitanaka A; Utsunomiya A; Ogawa S; Shimoda K
Haematologica; 2023 Aug; 108(8):2178-2191. PubMed ID: 36794502
[TBL] [Abstract] [Full Text] [Related]
10. Disruption to the FOXO-PRDM1 axis resulting from deletions of chromosome 6 in acute lymphoblastic leukaemia.
Sinclair PB; Cranston RE; Raninga P; Cheng J; Hanna R; Hawking Z; Hair S; Ryan SL; Enshaei A; Nakjang S; Rand V; Blair HJ; Moorman AV; Heidenreich O; Harrison CJ
Leukemia; 2023 Mar; 37(3):636-649. PubMed ID: 36670235
[TBL] [Abstract] [Full Text] [Related]
11. The dynamic functions of irf4 in B cell malignancies.
Maffei R; Fiorcari S; Atene CG; Martinelli S; Mesini N; Pilato F; Lagreca I; Barozzi P; Riva G; Nasillo V; Paolini A; Forghieri F; Potenza L; Trenti T; Tagliafico E; Luppi M; Marasca R
Clin Exp Med; 2023 Aug; 23(4):1171-1180. PubMed ID: 36495369
[TBL] [Abstract] [Full Text] [Related]
12. Analysis and therapeutic targeting of the EP300 and CREBBP acetyltransferases in anaplastic large cell lymphoma and Hodgkin lymphoma.
Wei W; Song Z; Chiba M; Wu W; Jeong S; Zhang JP; Kadin ME; Nakagawa M; Yang Y
Leukemia; 2023 Feb; 37(2):396-407. PubMed ID: 36456744
[TBL] [Abstract] [Full Text] [Related]
13. CARD11 mutation and HBZ expression induce lymphoproliferative disease and adult T-cell leukemia/lymphoma.
Kameda T; Shide K; Kamiunten A; Kogure Y; Morishita D; Koya J; Tahira Y; Akizuki K; Yokomizo-Nakano T; Kubota S; Marutsuka K; Sekine M; Hidaka T; Kubuki Y; Kitai Y; Matsuda T; Yoda A; Ohshima T; Sugiyama M; Sashida G; Kataoka K; Ogawa S; Shimoda K
Commun Biol; 2022 Nov; 5(1):1309. PubMed ID: 36446869
[TBL] [Abstract] [Full Text] [Related]
14. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract] [Full Text] [Related]
15. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas.
Jang JY; Hwang I; Pan H; Yao J; Alinari L; Imada E; Zanettini C; Kluk MJ; Wang Y; Lee Y; Lin HV; Huang X; Di Liberto M; Chen Z; Ballman KV; Cantley LC; Marchionni L; Inghirami G; Elemento O; Baiocchi RA; Chen-Kiang S; Belvedere S; Zheng H; Paik J
J Clin Invest; 2022 Dec; 132(24):. PubMed ID: 36282572
[TBL] [Abstract] [Full Text] [Related]
16. irf4 Gene Expression on the Trail of Molecular Response: Looking at Chronic Myeloid leukemia from Another Perspective.
Tarantini F; Cumbo C; Parciante E; Anelli L; Zagaria A; Coccaro N; Minervini CF; Tota G; Redavid I; Conserva MR; Attolico I; Rossi AR; Specchia G; Musto P; Albano F
Acta Haematol; 2023; 146(1):37-43. PubMed ID: 36195064
[TBL] [Abstract] [Full Text] [Related]
17. Druggable host gene dependencies in primary effusion lymphoma.
Kuehnle N; Gottwein E
Curr Opin Virol; 2022 Oct; 56():101270. PubMed ID: 36182745
[TBL] [Abstract] [Full Text] [Related]
18. Alvocidib inhibits irf4 expression via super-enhancer suppression and adult T-cell leukemia/lymphoma cell growth.
Sakamoto H; Ando K; Imaizumi Y; Mishima H; Kinoshita A; Kobayashi Y; Kitanosono H; Kato T; Sawayama Y; Sato S; Hata T; Nakashima M; Yoshiura KI; Miyazaki Y
Cancer Sci; 2022 Dec; 113(12):4092-4103. PubMed ID: 36047964
[TBL] [Abstract] [Full Text] [Related]
19. Single-cell ATAC-seq maps the comprehensive and dynamic chromatin accessibility landscape of CAR-T cell dysfunction.
Jiang P; Zhang Z; Hu Y; Liang Z; Han Y; Li X; Zeng X; Zhang H; Zhu M; Dong J; Huang H; Qian P
Leukemia; 2022 Nov; 36(11):2656-2668. PubMed ID: 35962059
[TBL] [Abstract] [Full Text] [Related]
20. ETS1 is a novel transcriptional regulator of adult T-cell leukemia/lymphoma of North American descent.
Luchtel RA; Zhao Y; Aggarwal RK; Pradhan K; Maqbool SB
Blood Adv; 2022 Oct; 6(20):5613-5624. PubMed ID: 35675522
[TBL] [Abstract] [Full Text] [Related]
[Next]
